CS217603B1 - Method of preparing compositions for dissolving renal calculi - Google Patents

Method of preparing compositions for dissolving renal calculi Download PDF

Info

Publication number
CS217603B1
CS217603B1 CS727556A CS755672A CS217603B1 CS 217603 B1 CS217603 B1 CS 217603B1 CS 727556 A CS727556 A CS 727556A CS 755672 A CS755672 A CS 755672A CS 217603 B1 CS217603 B1 CS 217603B1
Authority
CS
Czechoslovakia
Prior art keywords
weight
citrate
parts
magnesium
citric acid
Prior art date
Application number
CS727556A
Other languages
Czech (cs)
English (en)
Inventor
Joszef Nemes
Rudolf Szebeni
Mihaly Berenyi
Dezso Franc
Miklos Marso
Gyula Gal
Original Assignee
Joszef Nemes
Rudolf Szebeni
Mihaly Berenyi
Dezso Franc
Miklos Marso
Gyula Gal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joszef Nemes, Rudolf Szebeni, Mihaly Berenyi, Dezso Franc, Miklos Marso, Gyula Gal filed Critical Joszef Nemes
Publication of CS217603B1 publication Critical patent/CS217603B1/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS727556A 1971-11-08 1972-11-08 Method of preparing compositions for dissolving renal calculi CS217603B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI1185A HU165181B (ja) 1971-11-08 1971-11-08

Publications (1)

Publication Number Publication Date
CS217603B1 true CS217603B1 (en) 1983-01-28

Family

ID=10994422

Family Applications (1)

Application Number Title Priority Date Filing Date
CS727556A CS217603B1 (en) 1971-11-08 1972-11-08 Method of preparing compositions for dissolving renal calculi

Country Status (9)

Country Link
AT (1) AT332531B (ja)
CA (1) CA978479A (ja)
CS (1) CS217603B1 (ja)
DD (1) DD100631A1 (ja)
DE (1) DE2252665A1 (ja)
GB (1) GB1403900A (ja)
HU (1) HU165181B (ja)
IL (1) IL40685A (ja)
SU (1) SU1009467A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2826642C2 (de) 1978-06-19 1987-04-23 Dr. Madaus & Co, 5000 Köln Orales Urolithiasismittel
DE3046580A1 (de) * 1980-12-11 1982-07-01 Leskovar, Peter, Dr.-Ing., 8000 München Harnsteinaufloesende mittel
DE3728814A1 (de) * 1987-08-28 1989-03-30 Lentia Gmbh Loesung zur anwendung als spuelfluessigkeit in der zerstoerung von koerperfremden ablagerungen in menschlichen und tierischen geweben oder koerperhohlraeumen
JP2545479B2 (ja) * 1989-02-07 1996-10-16 ミッション ファーマカル カンパニー，インコーポレーテッド 医薬組成物
CA1326040C (en) * 1989-11-16 1994-01-11 Neill B. Walsdorf Magnesium-potassium citrate
DE4409949C2 (de) * 1994-03-23 1996-11-21 Madaus Ag Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes
DE10028167B4 (de) * 2000-06-09 2004-02-19 Storch, Rüdiger, Dr. Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen
US8603989B2 (en) 2008-05-22 2013-12-10 Bristol-Myers Squibb Company Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same
FR2967576B1 (fr) 2010-11-18 2013-07-12 Advicenne Pharma Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament
FR2967578B1 (fr) 2010-11-18 2012-12-28 Advicenne Pharma Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
MX352660B (es) * 2013-03-15 2017-12-04 Univ New York Bebida con contenido de citrato.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
FR2019261A1 (en) * 1969-03-19 1970-07-03 Melon Jean Marie Treatment of oxalic lithiase with succinic - acid and its derivs

Also Published As

Publication number Publication date
DD100631A1 (ja) 1973-10-05
AT332531B (de) 1976-10-11
GB1403900A (en) 1975-08-28
DE2252665C2 (ja) 1987-09-10
SU1009467A1 (ru) 1983-04-07
IL40685A (en) 1976-08-31
DE2252665A1 (de) 1973-05-10
IL40685A0 (en) 1972-12-29
CA978479A (en) 1975-11-25
ATA925372A (de) 1976-01-15
HU165181B (ja) 1974-07-27

Similar Documents

Publication Publication Date Title
EP0557065B1 (en) Spheroid formulation
US5211958A (en) Pharmaceutical composition and process for its preparation
CA1135190A (en) Effervescent analgesic powder
CA1040532A (en) Process for producing solid bismuth-containing pharmaceutical compositions
US6274168B1 (en) Phenytoin sodium pharmaceutical compositions
KR100311576B1 (ko) 경구투여용 항균성 조성물
US5460829A (en) Pharmaceutical compositions based on ebastine or analogues thereof
CS217603B1 (en) Method of preparing compositions for dissolving renal calculi
CZ289304B6 (cs) Farmaceutický prostředek ve formě efervescentních práąků nebo tablet, farmaceutický přípravek a způsob přípravy tohoto přípravku
DE69010563T3 (de) Wässrige Granulierungslösung und Verfahren zur Tablettengranulierung.
FI86799C (fi) Foerfarande foer framstaellning av skumbara blandningar
EP0159852A2 (en) Directly compressible pharmaceutical compositions
CA1201923A (en) Acesulfam-containing compositions, tablets on the basis thereof and process for the manufacture of these tablets
KR100351193B1 (ko) 아세틸살리실산메토클로프라미드화합물로구성된활성성분을갖는산제제조용조성물
US4190655A (en) Amiloride citrate
US4076804A (en) Erythromycin therapy
PL177607B1 (pl) Tabletka o opóźnionym uwalnianiu zawierająca sól sodową diklofenaku
US5935603A (en) Water soluble powder form compositions and their applications thereof
US6060498A (en) Composition containing antitumor agent
TR201610368A2 (tr) Geli̇şti̇ri̇lmi̇ş çözünme hizina sahi̇p si̇tagli̇pti̇n fosfat anhi̇drus formülasyonlari
JP2003515553A (ja) 発泡性ヒスタミンｈ２アンタゴニスト組成物
US2538092A (en) Water-soluble sulfaquinoxaline tablet
JP2545479B2 (ja) 医薬組成物
US3317391A (en) Composition for treatment of angina pectoris and process for preparing same
CA2247329C (en) Composition containing antitumor agent